Mechanisms of HIV latency

Conditions

HIV/AIDS

Phase COVID-NA

Volunteers
Health Professionals

What is the purpose of this trial?

participants will donate 150 ml of blood (around 5 ounces, less than 1/3 of a regular Red Cross blood donation) for each visit. Participants will be compensated. In some occasions, the study participants may be requested to donate for additional times, but no sooner than 8 weeks.

Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Trial with
Yale University School of Medicine
Start Date
04/18/2018
End Date
12/30/2048

For more information about this study, contact:

Ya-Chi Ho

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Ya-Chi Ho, MD, PhD, MMS
Assistant Professor of Microbial Pathogenesis and Medicine (Infectious Diseases); Investigator, HIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG); Investigator, BEAT-HIV Martin Delaney Collaboratory

Sub-Investigators

Last Updated
10/20/2020
Study HIC
#2000021845REG

Mechanisms of HIV latency

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information